로딩 중…
지수 로딩 중…
KOREA UNITED PHARM INC
033270· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩17,720-2.69%
2026-06-19
Price Chart
KOREA UNITED PHARM INC-15.42%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 281.94B KRW |
| Revenue | 291.23B KRW |
| Net Income | 39.64B KRW |
| Total Assets | 563.13B KRW |
| Net Assets | 459.17B KRW |
| Employees | 936 |
| Value | |
| P/E | 7.11x |
| P/B | 0.61x |
| PEG | 0.68x |
| P/S | 0.97x |
| EV/EBITDA | 25.11x |
| FCF Yield | 9.82% |
| Profitability | |
| ROE | 8.63% |
| ROA | 7.04% |
| Op. Margin | 16.16% |
| Revenue Growth | 3.46% |
| Earnings Growth | 10.49% |
| Financial Health | |
| Debt Ratio | 122.64% |
| Total Debt | 12.38B KRW |
| FCF | 27.69B KRW |
| Cash | 42.68B KRW |
| Current Ratio | 3.36x |
| Net Debt/EBITDA | -3.02x |
| Dividend | |
| Div. Yield | 3.35% |
| Div. Growth | 35.56% |
| Performance | |
| 1Y Return | -15.42% |
| 1M Return | -6.79% |
| From 52W High | -21.07% |
| 1Y MDD | -21.70% |
| Trading | |
| Volume | 32,410 shares |
| Foreign Own. | 7.75% |
| Per Share | |
| EPS | 2,431 KRW |
| BPS | 28,950 KRW |
Company Info
United Pharmaceutical, a specialized pharmaceutical manufacturer established in 1987 for the manufacture and sale of pharmaceuticals, was listed on KOSDAQ in 1999 and re-listed on KOSPI in 2007. Headquartered in Jeondong-myeon, Sejong Special Self-Governing City, the company maintains 7 affiliates including United Interpharm. It sells 18 improved new drugs and new formulation products, such as the antithrombotic treatment 'Silostan CR' (approx. 15% of sales) and the dyslipidemia treatment 'Artmac Combi-Gel' (approx. 10% of sales), to medical institutions and pharmacies nationwide.